Tenecteplase for Stroke - Opening the Window?
NEJM 390:760-761, Leifer,D.,, 2024
Treatment and Outcomes of Cervical Artery Dissection in Adults:A Scientific Statement From the American Heart Association
Stroke 55:e91-e106, YaghikS.,et al, 2024
Trial of Thrombectomy for Stroke with a Large Infarct of Unrestricted Size
NEJM 390:1677-1689, Costalat,V.,et al, 2024
Small Step or Giant Leap? Expanding the Acute Stroke Thrombolysis Window to 24 Hour
NEJM 391:273-275, Lee,V.H., 2024
Thrombolysis After Dabigatran Reversal for Acute Ischemic Stroke
Neurol 103:e209862, Theodorou,A.,et al, 2024
Endovascular vs Medical Management for Late Anterior Large Vessel Occlusion With Prestroke Disability
Neurol 100:e751-e763, Siegler, J.E., et al, 2023
Endovascular Therapy or Medical Management Alone for Isolated Posterior Cerebral Artery Occlusion: A Multicenter Study
Stroke 54:928-937, Sabben,C.,et al, 2023
Magnetic Resonance Imaging or Computed Tomography for Suspected Acute Stroke: Association of Admission Image Modality with Acute Recanalization Therapies, Workflow Metrics, and Outcomes
Ann Neurol 92:184-194, Fischer, U.,et al, 2022
Thrombectomy versus Medical Management in Mild Strokes due to Large Vessel Occlusion: Exploratory Analysis from the EXTEND-IA Trials and a Pooled International Cohort
Ann Neurol 92:364-378, Sarraj, A.,et al, 2022
Intravenous Thrombolysis with Tenecteplase for the Treatment of Acute Ischemic Stroke
Ann Neurol 92:349-357, Tsivgoulis, G.,et al, 2022
Intravenous Thrombolysis Before Endovascular Thrombectomy for Acute Ischemic Stroke
JAMA 325:229-231, Saver, J.L. & Adeoya, O., 2021
Changes in Stroke Hospital Care During the COVID-19 Pandemic
Stroke 52:3651-3660, Katsanos, A.H.,et al, 2021
Thrombectomy and Thrombolysis of Isolated Posterior Cerebral Artery Occlusion
Stroke 51:254-261, Strambo, D.,et al, 2020
Medical Management vs Mechanical Thrombectomy for Mild Strokes
JAMA Neurol 77:16-24, Goyal, N.,et al, 2020
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants
Stroke 51:533-541, Shahjouei, S.,et al, 2020
Melbourne Mobile Stroke Unit and Reperfusion Therapy
Stroke 51:922-930, Zhao, H.,et al, 2020
Dabigatran Reversal Before Intravenous Tenecteplase in Acute Ischemic Stroke
Stroke 51:1616-1619, Beharry, J.,et al, 2020
Reversible Diffusion-Weighted Imaging Lesions in Acute Ischemic Stroke
Neurol 94:571-587, Nagaraja, N.,et al, 2020
Thrombolysis for Acute Ischemic Stroke in the Unwitnessed or Extended Therapeutic Time Window
Neurol 94:e1241-e1248, Tsivgoulis, G.,et al, 2020
Thrombolysis before Thrombectomy - To Be or DIRECT-MT?
NEJM 382:doi:10.1056/NEJME2004550, Albers, G.W., 2020
Stroke Reperfusion Therapy Following Dabigatran Reversal with Idarucizumab in a National Cohort
Neurol 94:e1968-e1972, Barber, P.A.,et al, 2020
Association Between Thrombolytic Door-to-Needle Time and 1-Year Mortality and Readmission in Patients with Acute Ischemic Stroke
JAMA 323:2170-2184, Man, S.,et al, 2020
Thrombus Length Predicts Lack of Post-Thrombolysis Early Recanalization in Minor Stroke With Large Vessel Occlusion
Stroke 50:761-764, Seners, P.,et al, 2019
Recommendations for the Establishment of Stroke Systems of Care
Stroke 50:e1-e24, Adeoye, O.,et al, 2019
Systemic Review of Malpractice Litigation in the Diagnosis and Treatment of Acute Stroke
Stroke 50:2858-2864, Haslett, J.J.,et al, 2019
Primary Thrombectomy in tPA (Tissue-Type Plasminogen Activator) Eligible Stroke Patients with Proximal Intracranial Occlusions
Stroke 49:265-269, Fischer, U.,et al, 2018
2018 Guidelines for the Early Management of Patients with Acute Ischemic Stroke
Stroke 49:e46-e110, Powers, W.J.,et al, 2018
Tenecteplase versus Alteplase before Thrombectomy for Ischemic Stroke
NEJM 378:1573-1582, Campbell, B.C.V.,et al, 2018
Time to Decision and Treatment with tPA (Tissue-Type Plasminogen Activator) Using Telemedicine Versus an Onboard Neurologist on a Mobile Stroke Unit
Stroke 49:1528-1530, Bowry, R.,et al, 2018
MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
NEJM 379:611-622, 682, Thomalla, G.,et al, 2018
Intravenous Thrombolysis in Unwitnessed Stroke Onset: MR WITNESS Trial Results
Ann Neurol 83:980-993, Schwamm, L.H.,et al, 2018
Intravenous tPA (Tissue-Type Plasminogen Activator) in Patients with Acute Ischemic Stroke Taking Non-Vitamin K Antagonist Oral Anticoagulants Preceding Stroke
Stroke 49:2237-2240, Jin, C.,et al, 2018
Reduction in Time to Treatment in Prehospital Telemedicine Evaluation and Thrombolysis
Neurol 88:1305-1312, Taqui, A.,et al, 2017
Intravenous Thrombolysis in Acute Ischemic Stroke Patients Pretreated with Non-Vitamin K Antagonist Oral Anticoagulants
Stroke 48:2031-2033, Tsivgoulis, G. & Safouris, A., 2017
Favorable Bridging Therapy Based on DWI-FLAIR Mismatch in Patients with Unclear-Onset Stroke
AJNR 37:88-93, Mourand, I.,et al, 2016
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic STroke
Stroke 47:581-641, Demaerschalk, B.M.,et al, 2016
Cost-Effectiveness of Endovascular Thrombectomy in Patients with Acute Ischemic Stroke
Neurol 86:1053-1059, Aronsson, M.,et al, 2016
Streamlined Hyeracute Magnetic Resonance Imaging Protocol Identifies Tissue-Type Plasminogen Activator-Eligible Stroke Patients When Clinical Impression is Stroke Mimic
Stroke 47:1012-1017, Goyal, M.S.,et al, 2016
Clinicopathologic Conference, Cerebral Infarction from Internal Carotid Occlusion Related to Sickle Cell Arteriopathy
NEJM 374:1265-1275, Case 10-2016, 2016
Imaging, Intervention, and Workflow in Acute Ischemic Stroke: The Calgary Approach
AJNR 37:978-984, Zerna, C.,et al, 2016
Treatment of Carotid Intramural Thrombus with TPA
JAMA Neurol 73:1496, Bennett, A.,et al, 2016
Effects of Golden Hour Thrombolysis
JAMA Neurol 72:25-30,9, Ebinger, M.,et al, 2015
Thrombectomy within 8 Hours after Symptom Onset in Ischemic Stroke
NEJM 372:DOI:10.1056 NEJMoa1503780, DOI:1056NEJM e1503217, Jovin, T.G.,et al, 2015
Screening with MRI for Accurate and Rapid Stroke Treatment
Neurol 84:2438-2444, 2394, Shah, S.,et al, 2015
Treatment Concepts for Wake-Up Stroke and Stroke with Unknown Time of Symptom Onset
Stroke 46:2707-2713, Thomalla, G. & Gerloff, C., 2015
Basilar Occlusion Syndromes: An Update
Neurohosp 5:142-150, Demel, S.L. & Broderick, J.P., 2015
Endovascular Therapy is Effective and Safe for Patients with Severe Ischemic Stroke
Stroke 46:3416-3422, Broderick, J.P.,et al, 2015
Endovascular vs Medical Management of Acute Ischemic Stroke
Neurol 85:1980-1990, Chen, C.J.,et al, 2015
Unexplained Early Neurological Deterioration After Intravenous Thrombolysis
Stroke 45:2004-2009, Seners, P.,et al, 2014